Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Gareth Platt
University of Liverpool
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
24
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A modified vaccinia Ankara (MVA) virus vectored Zika vaccine that generates neutralising antibodies and potent T cell responses in type I interferon deficient mice
Number of pages: 35
Posted: 30 Jun 2026
Krishanthi Subramaniam
, Gareth Platt,
James Austin
,
Karen Buttigieg
,
John Bish
,
Naomi Coombes
,
Yper Hall
,
Lynsey Goodwin
,
Shona C. Moore
,
Sue Charlton
,
Hayley Hardwick
,
Tom Solomon
,
Gerd Sutter
,
Miles W. Carroll
,
Thomas Blanchard
,
Neil French
and
Lance Turtle
University of Liverpool - Department of Clinical Infection Microbiology and Immunology, University of Liverpool, University of Liverpool,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Public Health England - National Infection Service, UK Health Security Agency, University of Liverpool - Department of Clinical Infection, Microbiology and Immunology, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, Public Health England - National Infection Service, University of Liverpool, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, Ludwig Maximilian University of Munich (LMU), University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool, University of Liverpool and University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections
Downloads
24
View PDF
Download
Abstract:
Zika virus, modified vaccinia Ankara (MVA), T cells, antibodies, Vaccine, A129 mice
Feedback